Stephan Busque MD

General Surgery•Stanford, CA

Transplantation

Professor, Surgery - Multi-Organ Transplantation, Stanford University Medical Center

Join to View Full Profile

300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000

Education & Training

University of Montreal Faculty of MedicineClass of 1986

Certifications & Licensure

CA State Medical License 1993 - 2026
American Board of Surgery Surgery

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Start of enrollment: 2005 Jun 01
Completed
Phase 4
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs Start of enrollment: 2004 Jul 01
Active, not recruiting
Phase 1, Phase 2
Comparative Renal Function of Young (18-45 Years) and Ageing (55 Years and Above) Kidney Donors Start of enrollment: 2003 Mar 01
Completed
Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs. Start of enrollment: 2010 Jul 14
Active, not recruiting
Phase 1
Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation Start of enrollment: 2017 Feb 14
Recruiting
Early Phase 1
Roles: Principal Investigator
TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation Start of enrollment: 2020 Feb 01
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs. Start of enrollment: 2018 Sep 13
Recruiting
Phase 1
Roles: Principal Investigator, Contact, Sponsor-Investigator
Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy Start of enrollment: 2023 Oct 01
Not yet recruiting
Phase 1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Donor-Targeted Anti-HLA-A2 Antibody Shows Nanogram-Level Efficacy in a Novel GVHD Mouse Model.
Kouta Niizuma, Alyssa H Chang, Jeewon S Kim, Stephan Busque, Ravindra Majeti
Biorxiv. 2025-07-19
2 citations
Induction of immune tolerance in living related human leukocyte antigen-matched kidney transplantation: A phase 3 randomized clinical trial.
Dixon B Kaufman, Sanjeev K Akkina, Mark D Stegall, James B Piper, A Osama Gaber
American Journal of Transplantation. 2025-07-01
2 citations
Advocating for collaboration among key partners to promote diversity in clinical studies amid policy challenges in the United States of America.
Samuel Byiringiro, Juliana K Garcia, Nsenga Farrell, Bunmi Ogungbe, Rifath Ara Alam Barsha
Trials. 2025-04-02

Journal Articles

Review Macrochimerism and Clinical Transplant Tolerance
Samuel Strober, Stephan Busque, Edgar Engleman, Robert Lowsky, John D Scandling, Judith Shizuru, ScienceDirect

Press Mentions

Medeor Therapeutics to Provide Interim Results of Phase 3 Mercury Study of MDR-101 Cell Therapy in Living Donor Kidney Transplants During Rapid Fire Oral Presentation at ATC Virtual CongressMay 20th, 2021
Annual Awards Honor Outstanding Teaching, Patient CareJune 22nd, 2017

Stephan Busque MD

Dr. Busque is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.